2021

2020

Cash paid for interest

$

-

$

185,000

Non-cash investing and financing activities:

Termination of right of use lease asset

$

(744,000

)

$

-

Termination of right of use lease liability

$

744,000

$

-

Shares received for loan origination fee

$

(3,000,000

)

$

-

Shares received for prepaid loan interest

$

(2,440,000

)

$

-

Acquisition of APB net assets

$

38,765,000

-

Common A Shares issued for prepaid marketing services

$

-

$

210,000

Common A Shares issued for Impact BioMedical

$

-

$

3,132,000

Non-controlling interest related to Impact BioMedical

$

-

$

3,910,000

Series A Preferred Shares issued for Impact BioMedical

$

-

$

35,187,000

Notes receivable settled for assets in lieu of cash

$

-

$

838,000